Filter
508
Filtered Results: 508
Text search:
recall
of
health
products
Featured
Recommendations
44
New Publications
161
Language
Document type
No document type
321
Guidelines
58
Studies & Reports
53
Manuals
42
Training Material
19
Strategic & Response Plan
12
Fact sheets
3
Countries / Regions
Kenya
21
Nepal
18
Global
18
South Africa
14
Ethiopia
11
Uganda
11
Philippines
11
India
11
Myanmar / Burma
11
Tanzania
10
Malawi
10
Sierra Leone
9
Ghana
9
Zimbabwe
8
Zambia
8
Rwanda
8
Bangladesh
8
Nigeria
7
South–East Asia Region
7
Liberia
5
Namibia
5
Botswana
4
Latin America and the Carribbean
4
South Sudan
3
Syria
3
Indonesia
3
Sudan
3
Ukraine
3
Africa
3
Mali
2
Haiti
2
Jordan
2
Cambodia
2
Madagascar
2
Middle East and North Africa
2
Western Pacific Region
2
Western and Central Europe
2
Asia
2
Senegal
1
Congo, Democratic Republic of
1
Cameroon
1
Afghanistan
1
Egypt
1
Thailand
1
China
1
Papua New Guinea
1
Dominican Republic
1
Peru
1
Brazil
1
Colombia
1
Lesotho
1
Yemen
1
Eastern Europe and Central Asia
1
Venezuela
1
Mongolia
1
Southern Africa
1
Laos
1
Tajikistan
1
Australia
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
203
Clinical Guidelines
44
Public Health
43
Women & Child Health
37
Key Resources
34
Capacity Building
23
Pharmacy & Technologies
4
Toolboxes
Mental Health
39
COVID-19
31
Pharmacy
27
HIV
26
Caregiver
17
TB
16
Disability
14
Rapid Response
12
Global Health Education
9
Planetary Health
9
NCDs
9
Ebola
8
AMR
8
Conflict
7
Cholera
4
Social Ethics
4
Health Financing Toolbox
4
Polio
3
Natural Hazards
3
Zika
3
NTDs
3
Refugee
1
Specific Hazards
1
PMPB/INS-GUIDE/02
The WHO European Office for the Prevention and Control of Noncommunicable Diseases organized an expert meeting on monitoring of digital marketing of...
PQDx 0181-031-00
WHO PQ Public Report
March/2017, version 3.0
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected b...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern ... care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. Data from the WHO Global Database for Blood Safety (GDBS) brings out several inadequacies related to the supply and safety of blood and blood products. These inadequacies include a number of variations in safe blood practices across the world, including the quantity of blood donated (voluntary and replacement types), quality and adequate testing of the donated blood (immunohaematology [IH] and transfusion-transmitted infections [TTIs]), rational use of blood and blood components such as appropriate patient blood management protocols. These variations are very high in countries of the South-East Asian Region and most of them are either low- or middle-income countries (LMICs).
USAID/KENYA Evaluation Services and Program Support (ESPS)
The United States Agency for International Development (USAID) has a solid track record of supporting health and development initiativ...
The United States Agency for International Development (USAID) has a solid track record of supporting health and development initiativ...
The environment in which young people live, learn and play significantly affects their decisions about whether to consume alcohol. Environmental factors are the main risk factors driving alcohol consumption and related harm among young people. Environments that normalize alcohol consumption – term...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medic...
The provision of safe and efficacious blood and blood components for transfusion or manufacturing use involves a number of processes, from the selection o... blood donors and the collection, processing and testing of blood donations to the testing of patient samples, the issue of compatible blood and its administration to the patient. There is a risk of error in each process in this “transfusion chain” and a failure at any of these stages can have serious implications for the recipients of blood and blood products. Thus, while blood transfusion can be life-saving, there are associated risks, particularly the transmission of bloodborne infections.
Screening for transfusion-transmissible infections (TTIs) to exclude blood donations at risk of transmitting infection from donors to recipients is a critical part of the process of ensuring that transfusion is as safe as possible. Effective screening for evidence of the presence of the most common and dangerous TTIs can reduce the risk of transmission to very low levels.
Screening for transfusion-transmissible infections (TTIs) to exclude blood donations at risk of transmitting infection from donors to recipients is a critical part of the process of ensuring that transfusion is as safe as possible. Effective screening for evidence of the presence of the most common and dangerous TTIs can reduce the risk of transmission to very low levels.
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide...
WHO, in partnership with the International Society for Prosthetics and Orthotics (ISPO) and the United States Agency for International Development (USAID), has published global standards for prosthetics and orthotics. Its aim is to ensure that prosthetics and orthotics services are people-centred an...
The Abuja declaration identifies that the prevention and control of HIV/AIDS, tuberculosis and related infectious diseases must come with additional financial resources. Therefore, African governments agreed on setting the target ... allocating at least 15 per cent of each country’s annual budget to the improvement of the health sector. Moreover, the declaration demands donor countries to assist by fulfilling the target of delivering official development assistance (ODA) in the amount of 0.7 per cent of gross national product (GNP).
Drug Advisory Board
Training for Health Care Providers
Facilitators’ Manual
The harmonized training package for Point-of-use-fortification using micronutrient powders has been developed to guide in training frontline health workers. The micronutrient powders will be distrib...
